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Abstract

Resonance Raman (RR) spectroscopy is used to help define active site
structural responses of nanodisc-incorporated CYP3A4 to the binding of three
substrates: bromocriptine (BC), erythromycin (ERY), and testosterone (TST).
We demonstrate that nanodisc-incorporated assemblies reveal much more
well-defined active site RR spectroscopic responses as compared to those
normally obtained with the conventional, detergent-stabilized, sampling
strategies. While ERY and BC are known to bind to CYP3A4 with a 1:1
stoichiometry, only the BC induces a substantial conversion from low- to highspin state, as clearly manifested in the RR spectra acquired herein. The third
substrate, TST, displays significant homotropic interactions within CYP3A4,
the active site binding up to 3 molecules of this substrate, with the functional
properties varying in response to binding of individual substrate molecules.
While such behavior seemingly suggests the possibility that each substrate
binding event induces functionally important heme structural changes, up to
this time spectroscopic evidence for such structural changes has not been
available. The current RR spectroscopic studies show clearly that
accommodation of different size substrates, and different loading of TST, do
not significantly affect the structure of the substrate-bound ferric heme.
However, it is here demonstrated that the nature and number of bound
substrates do have an extraordinary influence on the conformation of bound
exogenous ligands, such as CO or dioxygen and its reduced forms, implying
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an effective mechanism whereby substrate structure can impact reactivity of
intermediates so as to influence function, as reflected in the diverse reactivity
of this drug metabolizing cytochrome.

Introduction
The membrane-bound human cytochrome P450 3A4 (CYP3A4),
the most abundant P450 expressed in liver and intestine, is involved in
the metabolism of almost 50% of all known pharmaceuticals and is
one of the most studied of the 57 human P450s.1-3 Its large active site
can accommodate substrates of diverse sizes, structures, and
affinities; depending on substrate size, it is also able to simultaneously
bind multiple substrate molecules, a situation that sometimes gives
rise to cooperative functional behavior.3-7 Homotropic cooperativity is
observed when an increasing concentration of substrate leads to
higher activity and atypical kinetics,3-7 while heterotropic cooperativity
is manifested when binding of an effector or second substrate molecule
can impact (stimulate or inhibit) catalytic activity toward a substrate.37

This ability to accommodate a wide range of substrate
structures, yet still retain active site structural constraints adequate to
impart regio- and stereoselectivity toward certain substrates,3-9 implies
the existence of a complex interplay between substrate structure and
active site structural elements, the understanding of which carries
important implications for drug development research.3-9 The practical
significance of this issue, coupled with a relatively small amount of
reliable structural data,10-14 has fueled a large number of
computational and modeling studies searching for insight into the
structural basis for substrate recognition and manipulation of the
inherent reactivity of CYP3A4.15-17
Although early crystallographic studies provided useful data for
the substrate-free form, efforts to acquire structures for substratebound forms were disappointing in that the substrates employed either
did not bind to the enzyme or bound in apparently unproductive
modes.10,11 However, recent studies have revealed that binding of
ketoconazole and erythromycin (ERY) causes dramatic, but different,
changes in protein conformation.12,13 Specifically, while the active site
volume increased by more than 80% in both cases, erythromycin
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binding resulted in a nonproductive complex, while two ketoconazole
molecules are accommodated within the heme active site. These
crystallographic data clearly support the position that drugmetabolizing cytochromes P450, such as CYP3A4, possess relatively
“malleable” pockets and that its active site structure and reactivity can
“adjust” in response to substrate structure. Given these observations
and the physiological importance of these enzymes, it is evident that
the development of successful protocols for application of a solution
phase technique capable of faithfully revealing active site structural
changes associated with binding of substrates, inhibitors, and
heterotropic effectors to mammalian cytochromes P450 is of immense
value.
Of the many spectroscopic techniques that have been effectively
applied to study heme proteins, resonance Raman (RR) has proven
itself to be quite versatile in documenting several types of critical
heme site structural changes.18,19 High frequency marker modes
respond to changes in oxidation- or spin-state of the central iron in
well-established and documented ways, while low frequency modes
indicate changes in protein interactions with the heme periphery.20-25
This is important, because the presence of the propionic acid and
(potentially conjugated) vinyl peripheral substituents has long been
considered as possibly important structural determinants of heme
reactivity, whose influence may be sensitively manipulated by
protein−heme interactions.23,26-28 Moreover, excitation within the
strong Soret band of the heme can lead to efficient enhancement of
internal modes of Fe−XY fragments, providing a very effective probe of
the key linkages between the heme prosthetic group and exogenous
ligands, including the CO molecule18,19,29-35 and the physiologically
relevant dioxygen and bound peroxo- and hydroperoxo fragments.36-42
While this powerful spectroscopic technique has long offered
great promise for application to mammalian P450s, certain
complications have persisted, one of the most problematical being the
propensity of these membrane-bound enzymes to aggregate in
solution in undefined and uncontrolled ways.43 In fact, this annoying
tendency toward aggregation is a general problem that has plagued all
biophysical studies of these systems. Fortunately, the so-called
“nanodisc” technology has been developed for use in mammalian
Journal of the American Chemical Society, Vol 133, No. 5 (February 9, 2011): pg. 1357-1366. DOI. This article is ©
American Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette.
American Chemical Society does not grant permission for this article to be further copied/distributed or hosted
elsewhere without the express permission from American Chemical Society.

4

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

cytochrome P450 research, permitting membrane-bound P450
enzymes to be studied in an environment that eliminates aggregation.
The nanodisc approach utilizes an encircling amphipathic membrane
scaffold protein (MSP), which can stabilize a phospholipid bilayer by
forming a kind of “belt” around the hydrophobic core,44,45 the essential
point being that this unique sampling methodology can now be used to
permit quite detailed characterization of the structure and function of
mammalian P450s in an environment that, for the first time, closely
mimics the native environment (Figure 1). In fact, the application of
the “nanodisc” technology to mammalian P450 research has already
enabled detailed studies of nanodisc-incorporated stoichiometric 1:1
complexes of CYPs and their natural reductases to form functional
organized catalytic assemblies.46-50

Figure 1. The nanodisc−CYP3A4 asembly. The CYP3A4 molecule is green, cartoon
representation, with heme shown in red sticks. Lipids are shown as sticks with
nitrogen atoms colored blue and oxygen in red, while the scaffold protein
encompassing the lipid bilayer is shown as a blue semitransparent surface with dark
blue sticks.

In this Article, attention is focused on the interactions of
nanodisc-incorporated CYP3A4 (designated ND:CYP3A4) with three
substrates, bromocriptine (BC), erythromycin (ERY), and testosterone
(TST), the functional properties for each of which have been
thoroughly documented (see Figure 2 for structures). The first of
these, BC, is a frequently studied 3A4 inhibitor/substrate that is
especially effective in inducing an almost complete change to the high
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spin (HS) state (∼95%).46,51 The choice of ERY stems from the fact
that, even though it does not induce a substantial spin state
conversion (only ∼20% HS), it is used in diagnostics as a test
substrate for CYP3A4.52 Those two substrates bind tightly to the
protein in the ratio of 1:1 with dissociation constants of ∼0.15 and
∼120 μM, respectively (unpublished results). Testosterone, an
important substrate of the steroid hydroxylases, is metabolized by
CYP3A4 and has been employed as a useful target for the study of
homotropic interactions within CYP3A4,46,49,50 which can bind up to
three molecules of this substrate. In these previous works, it was
found that the substrate-free nanodisc assembly is essentially a low
spin system, containing only 7% HS component; while binding of the
first TST substrate causes a small conversion to HS state and some
increase in consumption of NADPH reductant, there is no product
formed. Addition of the second substrate causes an almost complete
(98%) conversion to a HS state, but still yields rather low (5%)
coupling efficiency. Finally, the addition of the third substrate, while
not giving significant changes in spin state or turnover rate, does
improve coupling (up to 14%). Such observations obviously suggest
the likely possibility that each substrate binding event induces
functionally important heme structural changes, but up to this time
spectroscopic evidence for such structural changes has not been
available.

Figure 2. The structures of testosterone (A), bromocriptine (B), and erythromycin
(C).

Here, we present data for ferric resting states of the protein, in
both the substrate-free and the substrate-bound forms, which show
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remarkable differences in RR spectra collected for samples prepared in
commonly employed detergent and those acquired for ND:CYP3A4;
that is, while no substantial effects of substrate binding could be
observed in conventional media, quite distinct spectra were obtained
for the substrate-free and substrate-bound forms in these nanodisc
assemblies. More importantly, it is evident from the RR data acquired
here, for the first time, that the occupation of the distal pocket by
multiple substrates does not lead to structurally different high spin
states. However, the nature and number of bound substrates do have
a substantial influence on the conformation of bound exogenous
ligands, an observation that implies that substrate occupation may
impact mechanism by influencing the disposition of bound exogenous
ligands, such as dioxygen and its reduced (peroxo- and hydroperoxo-)
forms.

Experimental Section
Sample Preparation
Materials
All chemicals were purchased from Sigma Aldrich, with the
exception of chelating Sepharose FF and Superdex 200 (GE
Healthcare), Coomassie G-250 reagent (Pierce), Emulgen 913 (Karlan
Research Products, Santa Rosa, CA), and palmitoyl-oleoylphosphatidylcholine (POPC) (Avanti Polar Lipids, Alabaster, AL).

Protein Expression and Purification
Cytochrome P450 3A4 was expressed from the NF-14 construct
in the PCWori+ vector with a C-terminal pentahistidine tag generously
provided by Dr. F. P. Guengerich, as previously described.53 The
presence of the histidine-tag has been shown to not perturb the
measured turnover parameters of CYP3A4.54 Heterologous expression
and purification from E. coli was carried out using a modified
procedure46 as described in the Supporting Information of ref 55.
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Preparation of Nanodiscs Incorporated Protein
The application of the nanodisc system for solubilization of
integral membrane proteins incorporated into nanoscale bilayers has
been described in detail in several publications.46,56-60 Assembly of
human CYP3A4 in nanodiscs was accomplished using the scaffold
protein MSP1D1 with the poly(histidine) tag61 removed as described
previously.46 Briefly, purified CYP3A4 from the E. coli expression
system was solubilized by 0.1% Emulgen 913 and mixed with the disk
reconstitution mixture containing MSP1D1, POPC,1 and sodium cholate.
A molar mixing ratio of 0.1:1:65:130 (CYP3A4:MSP1D1:POPC:cholate)
was chosen to favor formation of monomeric CYP3A4 incorporated into
nanodiscs with the proper stoichiometry of scaffold protein and lipid.
Detergents are removed by absorption on the AmberliteXAD-2 (Sigma
Aldrich, Milwaukee, WI), which initiates self-assembly of nanodiscs.
Purification of the fraction of nanodiscs with incorporated CYP3A4 was
achieved using Ni-NTA affinity column followed by size exclusion
chromatography as previously described.55 The result of this selfassembly reaction is a monomer of CYP3A4 contained in a discoidal
POPC bilayer ∼10 nm in diameter stabilized by the encircling
amphipathic membrane scaffold protein belt. The CYP3A4-nanodiscs
were prepared in substrate-free form and kept at 4 °C. For
comparison, spectra also have been measured using CYP3A4
solubilized in 0.1% Emulgen 913.

Resonance Raman Measurements
Preparation of Samples for RR Measurements
The concentration of nanodisc-incorporated protein was ∼100
μM, unless otherwise specified. Electronic absorption spectroscopy
showed that this incorporated substrate-free (SF) sample contains
∼11% of high spin component, noting, however, that these absorption
measurements were performed on samples that were only 10−15 μM
in nanodisc concentration.51 The samples containing the relatively
large substrates were prepared by addition of 200 μM bromocryptime
(BC) or 800 μM erythromycin (ERY). To investigate the effect of TST
loading on the RR spectra, different concentrations of substrate were
added to substrate-free samples to give final concentrations of 100,
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130, 200, 350, 600, and 1200 μM; the ND:CYP3A4 samples were in
100 mM potassium phosphate buffer, pH 7.4. Concentrated solutions
of substrates in methanol-containing buffer solutions, where the final
concentration of methanol was always less than 1%, were added to
the substrate-free form.
The carbonmonoxy ferrous ND:CYP3A4 samples were prepared
in the following manner. Approximately 100 μL of ∼100 μM ferric
ND:CYP3A4 sample was placed in a 5 mm NMR tube (WG-5 Economy,
Wilmad) and closed with a rubber septum (Sigma-Aldrich, Milwaukee,
WI). The tube was connected to a vacuum line via a needle
connection, and the sample was degassed by three cycles of
alternating application of vacuum and filling with argon gas. Following
the final evacuation, CO gas was introduced to the NMR tube, and the
ferric sample was reduced by addition of ∼2 mol equiv (∼5 μL)62 of
sodium dithionite dissolved in freshly degassed 100 mM potassium
phosphate buffer, pH 7.4.
Samples were also prepared in so-called conventional media,
which consisted of 50 mM potassium phosphate, pH 7.4 buffer
containing 20% of glycerol, 1 mM DTT, and 0.1% of Emulgen 913 to
help ensure solubilization of CYP3A4 as a monomer. The concentration
of ferric samples of substrate-free CYP3A4 was 60 μM, and the
concentration of testosterone in the substrate-bound sample was 600
μM.

Resonance Raman Measurements
The ferric CYP3A4 samples were measured with the 406.7 nm
excitation line from a Kr+ laser (Coherent Innova model 100-K3), while
the Fe(II)−CO adducts were excited using the 441.6 nm line provided
by a He−Cd laser (Liconix model 4240). The RR spectra of all samples
were measured using a Spex 1269 spectrometer equipped with an
Andor Newton EMCCD detector (model DU971, Andor Technologies).
The slit width was 100 μm, and the 1200 g/mm and 2400 g/mm
gratings were used for lower resolution and high resolution
measurements, respectively. The laser power at the sample was
adjusted to ∼8 mW for ferric samples, while the power of ∼1 mW was
maintained for the CO adducts to minimize photodissociation. To avoid
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laser-induced heating and protein degradation, the samples were
contained in spinning NMR tubes (5 mm DO, WG-5 ECONOMY,
Wilmad). Measurements were done using a 180° backscattering
geometry, and the laser beam was focused onto the sample using a
cylindrical lens to form a line image.63 Spectra were calibrated with
fenchone and processed with Grams/32 AI software (Galactic
Industries, Salem, NH). Data were obtained at 4 and 30 °C. The
sample-containing NMR tube was placed in a homemade quartz Dewar
flask filled with water, and the temperature was monitored using a
thermocouple and did not change by more than ±2 °C during the
measurements.

Peak Fitting Procedure
The ν(Fe−CO) bands in the absolute spectra of substrate-free
and TS-bound samples exhibit clearly visible asymmetry, implying the
presence of several Fe−C−O conformers, an observation that was
confirmed by the appearance of distinct ν(C−O) stretches in the high
frequency region. To document the fractional population of these
multiple Fe−CO conformers, the low frequency RR spectra of ferrous
CO adducts were analyzed with Grams 32/AI software using a peak
fitting procedure, employing 50/50% Gaussian/Lorentzian functions.64
The fitting was performed in a manner that restricts the number of
peaks to the minimum, noting that this region also contains a wellknown heme mode.24,25 Thus, to obtain satisfactory fitting of Fe−CO
envelope, it was necessary to include this feature. First, its frequency
(and bandwidth) was derived by fitting of the less complex spectra of
the BC and ERY, yielding values of 501 cm−1 (15 ± 0.5 cm−1); it is
noted that these two fitting operations also produced virtually identical
relative intensities with respect to the ν7 mode at 673 cm−1, as would
be expected. Therefore, the parameters of this band, including its
intensity relative to the ν7 mode, were held constant in fitting all of the
other (more complex) spectra. The intensities, bandwidths, and
frequencies of the peaks associated with the ν(Fe−C) modes in the
spectra of the substrate-free sample and of the sample with high
concentration of TST were allowed to change during iteration cycles,
and it was found that their ν(Fe−C) envelopes were best fitted with
two ν(Fe−C) modes, results confirmed by the observation of two
ν(C−O) modes in the high frequency region. It is also noted that the
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ν(C−O) modes in the spectra of samples with smaller TST
concentrations have the same frequencies as the ν(C−O) modes in the
spectra of SF sample and sample containing a high concentration of
TST. Accordingly, while fitting spectra of those samples containing low
amounts of TST, the frequencies of the two ν(Fe−C) modes were kept
the same as extracted from the spectra of SF and high concentration
TST, while the bandwidths and intensities were allowed to change
during iteration cycles. Significantly, it is also noted that (within a
given spectrum) the relative intensities of the ν(Fe−C) modes are
consistent (within experimental error) with the relative intensities of
the two high frequency ν(C−O) modes.

Results and Discussion
Ferric P450 3A4 and Its Interaction with Substrates
Complications Arising from Detergent Solubilization
To document the differences in the RR spectra between CYP3A4
prepared in so-called “conventional” media and that assembled in
nanodiscs, two samples of cytochrome CYP3A4 were prepared in
detergent solution; as explained in the Experimental Section, these
contained Emulgen 913, which is commonly employed for enhancing
the solubility of mammalian cytochromes P450.43,50,64,65 The spectra of
the substrate-free enzyme, as well as that bound with 10 mol equiv of
testosterone, are shown in Figure 3 (traces A and B, “CM” stands for
“conventional media”, as opposed to nanodisc-incorporated proteins
that are the main subject of this Article). The so-called spin state
marker bands in these spectra are expected to occur near 1500 (v3),
1590 (ν2), and 1640 cm−1 (ν10) for the LS state and near 1490, 1570,
and 1630 cm−1 for the HS state.18,19,23-25,32 As can be readily seen in
the top trace, the ν3 spin state marker bands of the substrate-free
state indicate the presence of substantial amounts of both low (1502
cm−1) and high (1488 cm−1) spin components; however, it is noted
that the intensity ratio cannot be assumed to be directly proportional
to the spin state populations due to differences in inherent RR cross
sections. Given this fact, efforts were made here to deduce the relative
populations of LS and HS states by establishing the relative RR
scattering cross sections of the ν3 modes from studies of Cytochrome
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P450cam (CYP101), where it was possible to generate virtually pure HS
and LS samples, each containing 0.25 M sulfate ion as an internal
standard (the concentration of substrate-free sample was 11.7 μM,
and that of the substrate-bound was 11.1 μM); the relative cross
sections of the ν3 mode were determined to be IHS/ILS = 1.23
(unpublished data). This ratio was used to compute the HS and LS
popuations for spectra A and B of Figure 3, yielding HS/LS population
ratios of 30/70 for both. See Table S1 of the Supporting Information
for a summary of calculated spin state distributions for all samples
studied in this work. It is noted that the HS components of the ν2 and
ν10 modes are not readily observed, because of overlaps with other
modes (i.e., ν37 and ν(C═C)vinyl modes). Most interestingly, it can be
seen that the addition of substrate (testosterone in a 10-fold excess)
to this conventionally solubilized protein does not substantially affect
the spin state distribution of the enzyme (trace B), a result in stark
contrast to results normally obtained for most soluble bacterial
cytochromes P450, where binding of typical substrates causes
conversion of an almost pure LS state to population having 90−98%
HS component.25,32 The spectroscopic behavior observed here for these
detergent-solubilized proteins suggests that the “substrate-free”
sample shows some conversion to HS state due to the presence of the
Emulgen 913, which has been suggested to be a substrate for
mammalian P450s,64 but that the added TST substrate is to some
extent blocked from entering the active site, as reflected in the total
absence of further conversion to the HS state. The point to be made is
that the influence of Emulgen 913 and similar types of solubilizing
agents can introduce complications in studying the structural effects of
physiologically relevant substrates. As can be seen by inspection of the
data acquired here (e.g., Figure 3, traces C−F), such complications are
largely avoided for the nanodisc-incorporated systems.

Journal of the American Chemical Society, Vol 133, No. 5 (February 9, 2011): pg. 1357-1366. DOI. This article is ©
American Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette.
American Chemical Society does not grant permission for this article to be further copied/distributed or hosted
elsewhere without the express permission from American Chemical Society.

12

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Figure 3. The high frequency RR spectra of 60 μM ferric cytochrome CYP3A4 in
detergent without substrate (A), and with 600 μM testosterone (B), as well as RR
spectra of ferric cytochrome 3A4 in nanodiscs (100 μM) without substrate (C), with
1200 μM of testosterone (D), bromocriptine (E), and erythromycin (F). The RR spectra
were measured at 30 °C; excitation line 406 nm. Spectra were normalized to the ν3
mode. The “CM” stands for “conventional media” (traces A and B) as opposed to
spectra of protein incorporated in nanodiscs (traces C−F).

Effect of Substrate Structure on the Nanodisc-Incorporated Ferric
Enzyme
High Frequency Resonance Raman Spectra
The high frequency RR spectrum of the substrate-free form of
nanodisc-incorporated CYP3A4 (ND:CYP3A4) is presented in Figure 3,
trace C, exhibiting core size and spin state markers bands at 1502
cm−1 (ν3), 1568 cm−1 (ν2), and 1643 cm−1 (ν10), all being characteristic
of a low spin 6-coordinated state (LS6c), consistent with a thiolate
ligand coordinated on the proximal heme side and a water molecule on
the distal side, as is typical for substrate-free P450s.18,19,23-25,32 It is
emphasized here that, contrary to the samples prepared in detergent
solution, this sample is largely LS state (∼85%; Table S1). The
addition of high concentrations of testosterone (trace D), as well as
bromocriptine (trace E), causes significant increases in the HS
component, as judged by the strong intensities of the ν3 mode at 1488
cm−1 and the ν2 mode at 1570 cm−1. On the other hand, the addition
of ERY to the SF sample causes only slight spin state changes, the
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spectra of ERY-bound sample (trace F) looking esentially like that of
the substrate-free form, except for a very slightly enchanced HS ν3
mode at 1488 cm−1. These results are consistent with the UV−vis data
showing that the ERY-bound ND:CYP3A4 samples are only about 20%
high spin state.51
Returning attention to the results for the TST and BC-bound
forms, as shown in Table S1, the apparent HS population of the TSTbound form is 75%, while that of the BC-bound form is 80%. It is
noted that these values are slightly lower than those previously
reported for 1 μM ND:CYP3A4 samples containing 1 μM BC and high
concentrations of TST. As is explained further in the Supporting
Information, these small apparent discrepancies are most reasonably
attributed to the large differences in substrate and protein
concentrations, as well as small errors introduced by uncertainties in
the relative RR cross sections between the HS and LS bands (see the
Supporting Information).
Low Frequency Resonance Raman Spectra
The low frequency RR spectra of ferric samples of substratefree, BC- and ERY-bound, as well as that of a sample containing a
large amount of TST (1200 μM) are shown in Figure 4. The low
frequency spectrum of substrate-free ND:CYP3A4 (Figure 4, trace A)
exhibits two modes associated with “propionate bending” at 370 and
378 cm−1, and two modes assigned to “vinyl bending” modes, a lower
intensity one at 411 cm−1 and higher intensity mode at 423 cm−1; the
quotation marks are included in these descriptions in compliance with
more recent studies that have documented involvement of other
pyrrole substituents, as reflected in the rather substantial isotopic
shifts observed upon deuteration of the peripheral methyl groups.66,67
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Figure 4. The low frequency RR spectra of ferric cytochrome 3A4 in nanodiscs without
substrate (A), with 1200 μM of testosterone (B), bromocriptine (C), and erythromycin
(D). The RR spectra were measured at 30 °C; excitation line 406 nm. Spectra were
normalized to the ν8 mode.

The addition of BC or high concentrations of TST, which caused
substantial changes in spin-state marker modes, leads to small, but
definite, changes in the modes associated with heme peripheral group
dispositions or out-of-plane macrocycle distortion. Thus, the traces for
TST and BC bound samples exhibit only slight increases in the
intensities of the out-of-plane heme modes observed near 315−330
cm−1 and at ∼500 cm−1. Similarly, binding of substrate seems to
induce a rather small decrease of the lower frequency propionate
bending mode near 370 cm−1 and a corresponding increase in the
stronger propionate mode at 378 cm−1; it is interesting to note that
this effect on propionate modes is opposite of that observed for
bacterial P450s, where binding of substate led to activation of the
lower frequency propionate bending mode.23,25 The only obvious effect
on the vinyl modes is that the substrate-bound forms seem to have
larger intensities in the lower frequency component (near 410 cm−1) as
compared to the feature near 420 cm−1. The binding of ERY does not
induce any detectable enhancement of out-of-plane modes, but
slightly increases the lower frequency vinyl bending mode intensity,
relative to the 423 cm−1 feature.
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Effects of Loading of Smaller Substrates on Ferric CYP3A4
Inasmuch as it has been shown that up to three testosterone
molecules can bind within the large distal pocket of CYP3A4,46,50 it is of
interest to probe this system at different levels of TST loading so as to
provide an evaluation of the effect of pocket crowding on heme
structure. As is shown in Figures S1 and S2 of the Supporting
Information, while addition of increasing concentrations of TST causes
HS markers and low frequency oop modes to increase and LS markers
to decrease, there is no evidence for more than one type of HS
component. Thus, the results obtained argue that one molecule of TST
is apparently insufficient to trigger a spin state conversion, two bound
TST molecules generate a substantial HS population, which is further
populated by the third TST without causing any further distinct heme
structural changes.

Ferrous CO P450 3A4 and Its Interaction with
Substrates
The RR spectra of relatively stable ferrous CO adducts of
cytochrome P450 provide useful information about distal side pocket
structure and ligand protein interactions. Moreover, the changes in the
modes associated with the Fe−C−O fragment reflect not only strength
of the proximal trans ligand, but also the polarity of the distal pocket
environment, such as H-bond interaction with the distal amino acids,
water molecules, or substrates. It is well-known that back-donation of
the Fe(II) dπ electrons to ligands π* orbitals increases the Fe−C while
weakening the C−O bond strengths, resulting in a negative linear
correlation between the C−O and Fe−C stretching frequencies.18,19,2932,35
The ν(Fe−C) and ν(C−O) stretching modes are usually observed
in the regions of 460−490 and 1920−1970 cm−1, respectively, while
the δ(Fe−C−O) bending mode is seen at around 560−570 cm−1.18,19,2932,35
The spectra of ferrous CO samples were measured with the 442
nm excitation line at 4 °C; in all cases, there were no observed
differences in the spectra measured at 4 and 30 °C.

Journal of the American Chemical Society, Vol 133, No. 5 (February 9, 2011): pg. 1357-1366. DOI. This article is ©
American Chemical Society and permission has been granted for this version to appear in e-Publications@Marquette.
American Chemical Society does not grant permission for this article to be further copied/distributed or hosted
elsewhere without the express permission from American Chemical Society.

16

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

Effect of Substrate Structure on the Ferrous CO Adducts
The oxidation and spin-state marker bands of these low spin 6coordinate CO adducts occur at virtually identical positions, regardless
of substrate occupation, as expected (Figure S3, Supporting
Information); that is, the ν4 mode is located at 1371 cm−1, the ν3
mode at 1496 cm−1, and the ν2 mode at 1586 cm−1. In accordance
with this observation, it is also seen by inspection of Figure 5 that
there are no significant effects of substrate binding or substrate
structure on the low frequency heme modes that occur between 200
and 850 cm−1. However, substrate binding does have a definite impact
on the disposition of the Fe−C−O fragment, as judged by obvious
changes in its vibrational parameters; that is, the ν(Fe−C) modes shift
between 476 and 491 cm−1 and in certain cases appear to be
asymmetric, implying the existence of two or more conformers. To
evaluate these possibilities, the low frequency spectra were
deconvoluted and supplemented by spectra acquired between 1800
and 2100 cm−1, where corresponding ν(C−O) modes are expected to
occur, these spectra being displayed in Figure 6.

Figure 5. The low frequency RR spectra of ferrous CO adducts of cytochrome 3A4 in
nanodiscs without substrate (A), with 1200 μM of testosterone (B), bromocriptine (C),
and erythromycin (D). The RR spectra were measured at 4 °C; excitation line 442 nm.
Spectra were normalized to the ν7 mode.
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In the low frequency spectrum of the substrate-free sample, the
asymmetric peak at around 476 cm−1 is fit best with two peaks of 23
cm−1 bandwidth corresponding to two ν(Fe−C) conformers positioned
at 476 and 491 cm−1 (Figure 6, trace A). This assignment is supported
by the observation of two ν(C−O) stretches in the high frequency
region, at 1929 and 1953 cm−1 (inset of trace A). It is also important
to note that the relative intensities of these modes are well correlated;
that is, the modes at 476 and 1953 cm−1 are more intense and
represent one Fe−CO conformer, while the less intense pair of modes
at 491 and 1929 cm−1 corresponds to the second conformer.
Upon binding the relatively large BC substrate, it appears that
only one conformer is generated; that is, the feature observed at 484
cm−1 is fitted well with only one peak, whose 23 cm−1 bandwidth is
consistent with those seen for the two conformers of the substratefree form. Again, this interpretation is clearly supported by the
observation of a single ν(C−O) mode appearing at 1935 cm−1. The
presence of only one mode in BC-bound sample implies that this
substrate occupies a large portion of heme pocket, permitting only one
Fe−C−O conformer. The spectra of ERY-bound sample also show only
one ν(Fe−C) stretch occurring at 479 cm−1 and its corresponding
single ν(C−O) mode at 1948 cm−1. Interesting aspects of this ν(Fe−C)
mode of the ERY-bound sample are that it possesses a very narrow
bandwidth (14 cm−1) and exhibits a remarkably high intensity, being
comparable to the intense ν7 mode (Figure 5, trace D). The narrowing
and high intensity of this mode is possibly associated with a very rigid
conformation of the Fe−CO fragment and possible hydrogen bonding
to the ERY substrate, a suggestion that is consistent with previously
reported X-ray crystallographic data.68
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Figure 6. High-resolution low frequency RR spectra of ferrous CO adducts of
cytochrome 3A4 in nanodiscs without substrate (A), with 200 μM bromocriptine (B),
with 800 μM erythromycin (C), with 130 μM of testosterone (D), with 200 μM of
testosterone (D), and with 350 μM of testosterone (E). Note the samples with 350,
600, and 1200 μM of testosterone give the same spectra. The RR spectra were
measured at 4 °C; excitation line 442 nm. Spectra were normalized to the ν7 mode
and deconvoluted as described in text. Black solid line, experimental data; green solid
line, fitted spectra; red dotted line, modes associated with ν(Fe−CO) modes; black
dotted line, other modes in this region. The insets show the high frequency region of
corresponding samples.

Effect of Substrate Loading on Ferrous CO Adducts
Also shown in Figure 6 are the spectra of ND:P4503A4 with
different loadings of TST. The ν(Fe−C) envelope observed for the 130
μM TST sample (Figure 6, trace D) is very wide and asymmetric,
requiring application of the deconvolution procedures. Inasmuch as the
corresponding ν(C−O) modes are seen at the same frequencies
observed for the substrate-free form (i.e., at 1929 and 1953 cm−1), it
was deemed most appropriate to also use the same initial ν(Fe−C)
frequencies observed for the substrate-free form and then attempt
different fitting strategies. First, the frequencies and intensities were
allowed to vary, while holding the bandwidths constant, the net result
being that a satisfactory fit was not attainable. On the other hand,
when the frequencies were held constant, allowing the intensities and
bandwidths to vary, a satisfactory fit was quickly attained, yielding two
ν(Fe−C) modes having bandwidths of 23 and 17 cm−1 for the 476 and
491 cm−1 features, respectively; that is, a selective narrowing of the
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high frequency component was observed. The addition of TS to a total
of 200 μM caused further increases in the relative intensity of the
higher frequency component, noting the interesting fact that a
satisfactory fit could only be obtained by permitting a comparably
narrow bandwidth to the lower frequency Fe−C mode. Further
additions of TST to 350 μM yielded higher percentages of the 491 cm−1
component, but no further narrowing of either feature. Finally, it is
emphasized that the observed intensity variations of the corresponding
ν(C−O) modes upon loading of TST are entirely consistent with the
parameters extracted from the low frequency deconvolution
procedure. These observations lead to the conclusion that higher TST
loadings reduce, although not completely eliminate, the population of
Fe−CO conformer that is dominant in the substrate-free form.
Furthermore, the apparently crowded distal pocket leads to more
restricted conformations, as reflected in the narrower bandwidths
observed at higher loadings of TST.

Figure 7. The inverse correlation between the ν(Fe−C) and ν(C−O) frequencies. The
“” represent points for the ND:CYP3A4, and the “◆” are for the CYP101 proteins
(from refs 31,32,69−71).

Plots of the ν(C−O) versus the ν(Fe−C) frequencies represent
the FeCO backbonding correlation and provide very useful information,
not only about proximal ligand effects, but also the distal heme pocket
environment, including steric distortions of the Fe−C−O fragment and
polarity of the distal heme pocket. It is generally accepted that a
positive polar distal environment, including H-bonding, causes
lowering of the ν(CO) and a corresponding increase of the ν(Fe−C)
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frequency, yielding points to the left side of the correlation. As shown
in Figure 7, the ν(C−O)/ν(Fe−C) points observed for the ND:CYP3A4
preparations studied here document increases in positive polarity upon
binding of various substrates. Behavior similar to this has been
observed for CYP101, as shown in the lower correlation line in Figure
7, and interpreted as being indicative of H-bond formation with distal
pocket Thr and Asp residues upon exclusion of the distal pocket water
clusters present in the substrate-free form.31,32,69-72 Addition of BC and
TST substrates to the ND:CYP3A4 samples results in more polar
environments in the vicinity of the Fe−CO fragment, with the TST
having the strongest effect. Binding of the ERY substrate leads to
formation of an apparently weaker, but highly directed H-bonding
interaction that results in narrow and intense ν(Fe−C) and ν(C−O)
features. The observed ability of this protein to accommodate three
such structurally different substrates reflects the anticipated flexibility
of the large distal pocket. On the other hand, the observed differential
effects of these substrates on the vibrational parameters (disposition)
of the Fe−CO fragment imply that the structure of substrate can
indeed impact the CYP3A4 reactivity and function.

Conclusions
Several important findings have emerged from the present
work. First, the use of the nanodisc sampling methodology, which had
previously been shown to elicit more well-behaved functional
properties, is now shown to lead to a system with well-defined spectral
parameters that are indeed responsive to substrate binding in a
manner that is consistent with observed functional changes. The
binding of TST in high concentrations, as well as binding of BC, result
in large spin shifts, while binding of ERY causes only a slight spin shift.
In the low frequency region, there are only minor changes in the
modes associated with out-of-plane macrocycle distortion or heme
peripheral group dispositions, a finding that contrasts with the
behavior typically observed for bacterial P450s. Significantly, although
several new RR features associated with out-of-plane or peripheral
group bending modes appear in the LF spectral region when TST is
added, it is noted that there is apparently only one type of high-spin
state, whose structure is not sensitive to the number of bound TST
molecules.
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Although there are no noticeable effects of substrate structure
or loading on the heme spectral features, there are definite differences
observed for the modes associated with the Fe−CO fragment, with
shifts of up to 15 cm−1 being seen. This strong effect of some
substrates on the vibrational spectra of Fe−CO unit in cytochromes
P450 is usually attributed to the steric and/or electronic perturbation
caused by interactions with the bound ligand. While comparable shifts
upon substrate binding are commonly observed for bacterial
P450s,18,19,25 they are generally not seen for most mammalian
cytochromes P450, when studied in conventional media; for example,
very small effects on the vibrational modes of the Fe−C−O fragments
were observed for CYP2B4 upon binding of substrates.24 Although it is
true that relatively large changes in the Fe−C and C−O stretching
modes have been reported for the CO adduct of CYP19 upon binding of
its substrate, 19-oxo androstenedione,73 it is noted that this is a type
of steriodogenic cytochrome P450 that typically exhibits high
sterospecificity, implying a tightly organized binding site more similar
to those of bacterial P450s.
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